Companies
Neuralink
NeuralinkSan Francisco, CA
Founded 2016
Healthcare
Last Round Valuation
$3.48B
Last Round Share Price
$ XX.XY
Total Funding
$644M
Last Round
Series D
Neuralink
$56.98
1M
3M
YTD
1Y
2Y
MAX
Prices in chart are based on estimates only based on historical market data. These are not liquid investments.
Funding Rounds
Nothing here |
Information contained herein is based on estimates and is subject to update.
News
05/26/2025
Neuralink Secures $650 Million in Series E Funding, Valuation Reaches $9 Billion
Neuralink's substantial funding round not only solidifies its market position but also accelerates the development of brain-computer interfaces, potentially transforming healthcare and technology sectors while attracting increased investor interest in neurotechnology innovations.
05/18/2025
Neuralink Launches First International Clinical Trial in Abu Dhabi
Neuralink's international clinical trial in Abu Dhabi signals a strategic expansion into global markets, potentially accelerating advancements in neurotechnology and attracting investment in the burgeoning field of brain-computer interfaces.
05/10/2025
Elon Musk's Neuralink Sparks Debate on AI and Future of Smartphones
Neuralink's advancements could redefine human-computer interaction, potentially diminishing the role of traditional smartphones and reshaping tech ecosystems, while raising critical ethical questions about AI integration in daily life.
Research
Research reports obtained through third party are for informational purposes only.
Let us know if we are missing anything
FAQ
What is Augment?
Does Augment protect my privacy?
Who can use Augment?
Does my company allow sales of shares?
Which companies are listed on Augment’s marketplace?
What is required to join Augment?
How can I get notified when there are new interested buyers of my shares?
Are orders posted anonymously?
How do Augment fees work?
How do I know what price to buy or sell shares?
What size transactions does Augment support?
How do I know if an order is created by a broker or a direct buyer or user?
Is trading on Augment safe and legitimate?
What is the typical process of selling shares?
© Augment 2023 — All rights reserved. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, in addition to financial products and services through its wholly-owned but separately managed subsidiary, Augment Capital, LLC.
Securities products are offered through Augment Capital, LLC, member FINRA/ SIPC. Any information relating to fully diluted shares outstanding or other company related financing or capitalization information are estimates only and should be independently verified by each user in connection with any investment decision. Company data and portfolio calculations are provided by Augment for educational and illustrative purposes only. None of the information displayed on or downloadable from augment.market (the "Website") represents a recommendation, offer, solicitation of an offer, advice, or recommendation to buy, sell, or hold any security. All investing involves risk, including the risk of losing the money you invest, and past performance does not guarantee future performance.
Using the website or the information, tools, features or functionality provided on the website and by Augment Capital, LLC constitutes acceptance of the Augment terms of use, privacy policy, and other important disclosures. Review our Form CRS here.